Efficacy of scheduled intravenous acetaminophen administration for catheter-related bladder discomfort in patients after transurethral resection of bladder tumors: A prospective randomized pilot study

被引：0

作者：

Hatayama, Tomoya ^{[1
,2
]}

Mita, Koji ^{[1
]}

Kohada, Yuki ^{[2
]}

Fujiyama, Kenta ^{[1
]}

Tasaka, Ryo ^{[1
,2
]}

Goriki, Akihiro ^{[1
,2
]}

Mochizuki, Hideki ^{[1
,3
]}

Hinata, Nobuyuki ^{[2
]}

机构：

[1] Asa Citizens Hosp, Hiroshima City North Med Ctr, Dept Urol, 1-2-1 Kameyama Minami,Asakita Ku, Hiroshima 7310293, Japan

[2] Hiroshima Univ, Grad Sch Biomed Sci, Dept Urol, Hiroshima, Japan

[3] Natl Hosp Org Higashihiroshima Med Ctr, Dept Urol, Hiroshima, Japan

来源：

INVESTIGATIVE AND CLINICAL UROLOGY | 2025年 / 66卷 / 02期

关键词：

Bladder tumor; Pain management; Quality of life; Urinary bladder; Urinary catheters; DEXMEDETOMIDINE; PARACETAMOL; PREVENTION; MANAGEMENT;

D O I：

10.4111/icu.20240357

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose: Scheduled administration of intravenous acetaminophen improves catheter-related bladder discomfort (CRBD) after urological surgery. However its efficacy for patients undergoing transurethral resection of bladder tumors (TURBT) remains unclear. This study aimed to investigate the efficacy of scheduled administration of intravenous acetaminophen after TURBT. Materials and Methods: At the end of surgery, patients in both the control (n=39) and the scheduled administration (n=45) groups received analgesics at the discretion of the anesthesiologists. In the scheduled administration group, intravenous acetaminophen was administered every 4 hours for 12 hours after the surgery. Both groups were administered on-demand analgesics as needed. The primary outcome was CRBD scores, and the secondary outcomes were the face rating scale for lower abdominal pain, administration rates of additional analgesics, durations of bladder catheterization, lengths of postoperative hospital stay, and postoperative complication rate. Results: The scheduled administration group had significantly lower CRBD scores than those of the control group at 8 hours postoperatively (p=0.014), and lower administration rates of additional analgesics 4-8 hours (p=0.029) and 8-12 hours (p=0.027) postoperatively compared to those of the control group. Other secondary outcomes were not significantly different between the groups (all p>0.05). The scheduled administration group did not have postoperative complications related to the scheduled administration of intravenous acetaminophen. Conclusions: Scheduled intravenous acetaminophen administration alleviated postoperative CRBD and reduced the need for additional analgesics in patients who underwent TURBT. These findings can be utilized to improve the quality of postoperative care.

引用

页码：144 / 151

页数：8

共 27 条

[21]

Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Et al., The American Urological Association symptom index for benign prostatic hyperplasia. The Measure-ment Committee of the American Urological Association, J Urol, 148, pp. 1549-1564, (1992)

[22]

Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Et al., Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score, Urology, 68, pp. 318-323, (2006)

[23]

Zi H, He SH, Leng XY, Xu XF, Huang Q, Weng H, Et al., Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019, Mil Med Res, 8, (2021)

[24]

Cho S, Park WJ., Twenty-two-year incidence trend of urologi-cal cancers in the Republic of Korea: 1999-2020, Investig Clin Urol, 65, pp. 23-31, (2024)

[25]

Sasaki T, Higashi T, Inoue T., Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan, Int J Clin Oncol, 29, pp. 1088-1095, (2024)

[26]

Shinoda M, Nishimura A, Sugiyama E, Sato H, Iijima T., Optimal timing of intravenous acetaminophen administration for postoperative analgesia, Anesth Prog, 69, pp. 3-10, (2022)

[27]

Maghsoudi R, Tabatabai M, Radfar MH, Movasagi G, Etemadi-an M, Shati M, Et al., Opioid-sparing effect of intravenous paracetamol after percutaneous nephrolithotomy: a double-blind randomized controlled trial, J Endourol, 28, pp. 23-27, (2014)

← 1 2 3 →